Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

Annals of Internal Medicine

Volumn 135, Issue 11, 2001, Pages 939-953

  Hodis, H N ^a   Mack, W J ^a   Lobo, R A ^a   Shoupe, D ^a   Sevanian, A ^a   Mahrer, P R ^a   Selzer, R H ^a   Liu, C R ^a   Liu, C H ^a   Azen, S P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; ESTRADIOL; ESTROGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; MEVINOLIN; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; B SCAN; BREAST CANCER; BREAST HYPERPLASIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMMON CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; ENDOMETRIUM HYPERPLASIA; ESTROGEN THERAPY; FEMALE; HUMAN; IMAGE PROCESSING; INTIMA; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PATIENT COUNSELING; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035808009     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-135-11-200112040-00005     Document Type: Article

References (54)

1. Myocardial infarction in women
2. Menopause and risk of cardiovascular disease: The Framingham study
3. Menopause and the risk of coronary heart disease in women
4. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women
5. Estrogen for women at varying risk of coronary disease
6. Postmenopausal estrogen and prevention bias
7. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound
8. One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy
9. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: A randomized controlled clinical trial
10. The role of carotid arterial intima-media thickness in predicting clinical coronary events
11. Carotid artery intima-media thickness and risk of cardiovascular events
12. Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography
13. Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images
14. Improved common carotid elasticity and intima-media thickness measurements from computer analysis of sequential ultrasound frames
15. An ultrasonic measurement of superficial femoral artery wall thickness
16. Random-effects models for longitudinal data
17. A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries
18. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: The Carotid Atherosclerosis Italian Ultrasound Study
19. Arterial imaging and atherosclerosis reversal
20. Ultrasound B-mode imaging in observational studies of atherosclerotic progression
21. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study 1987-1993
22. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study
23. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in oldet adults
24. Risk factors and noncontraceptive estrogen use in women with and without coronary disease
25. Postmenopausal use of estrogen and occlusion of coronary arteries
26. Postmenopausal estrogen use and coronary atherosclerosis
27. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women
28. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women
29. Age-related deterioration in arterial structure and function in postmenopausal women: Impact of hormone replacement therapy
30. Hormone replacement therapy and intima-media thickness of the common carotid artery: The Rotterdam study
31. No association of menopause and hormone replacement therapy with carotid artery intima-media thickness
32. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
33. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women
34. Effects of lovastatin and warfarin on early carotid atherosclerosis: Sex-specific analyses
35. Estrogen replacement therapy II: A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems
36. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy
37. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement
38. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
39. Effect of estrogen and progestin on progression of carotid atherosclerosis in postmenopausal women with documented heart disease: HERS B-mode sub-study
40. Medroxy-progesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis
41. Estrogen only versus estrogen + progestin replacement therapy: Effects on coronary artery atherosclerosis extent and carotid artery intima-media thickness
42. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
43. Effect of 17 beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits
44. Estrogen modulates responses of atherosclerotic coronary arteries
45. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys
46. Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papio sp.)
47. Hormone replacement therapy, inflammation, and hemostasis in elderly women
48. Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
49. Hormone replacement therapy and increased plasma concentration of C-reactive protein
50. Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women
51. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
52. Estrogen and cardiovascular disease